Navigation Links
Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVault's Board of Directors
Date:6/12/2008

CARLSBAD, Calif., June 12 /PRNewswire/ -- GenVault Corporation today announces Paul J. Mirabella, Chairman and CEO of Naviscan PET Systems Inc., has joined its Board of Directors. Mr. Mirabella has more than 30 years of experience in diagnostic imaging with GE Healthcare where he held leadership roles in technology, marketing and global business management. Drawing on this substantial background in diagnostics and the healthcare market, he will help guide GenVault's entry into new biosample management markets as well as streamline operational efficiencies.

"Mr. Mirabella's deep business experience and understanding of the healthcare industry will be extremely valuable as we develop new technologies to expand our addressable markets. We are extremely honored to welcome Mr. Mirabella as a key member of the GenVault team," said David Wellis, CEO of GenVault.

"Biosamples are the conduit of information from the patient to clinicians and researchers. Advances in the handling of these samples will result in more efficient diagnosis, therapy development and ultimately a healthier population. I'm pleased to participate in building such a critical solution," said Mr. Mirabella.

Mr. Mirabella's previous experience includes leadership roles at GE Healthcare in ultrasound, computed tomography (CT), magnetic resonance, and sales and services. Mr. Mirabella holds four patents in CT and has participated in a variety of successful global product launches. Prior to joining Naviscan, he was President and CEO of Global Diagnostic Imaging, while retaining responsibility for the commercial leadership of sales, marketing and services in the Americas. Mr. Mirabella obtained degrees in aerospace engineering and applied mechanics from Polytechnic Institute of New York and a Masters in mechanical engineering from the University of Central Florida. He is a graduate of the GE Business Management Program accredited by the University of Wisconsin-Whitewater.

Mr. Mirabella is also on the Board of Directors for the Vince Lombardi Charitable Funds in Milwaukee, the RSNA Research and Education Board, AMIRSYs, Inc., served on the Wisconsin Governor's Economic Council, and an owner/director of several private companies in Wisconsin.

About GenVault

GenVault is the global leader in providing biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable and reliable alternative to traditional freezers and DNA purification systems, the company's dry state platform enables the extraction, preservation, recovery, and distribution of DNA at room temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for DNA sample management and preservation. For more information visit GenVault at http://www.genvault.com

EDITORIAL CONTACTS:

David Wellis, CEO or

Kerri McWeeny, Director of Marketing

GenVault Corporation

(760) 268-5256


'/>"/>
SOURCE GenVault Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Lillys Connelly Appointed to the Presidents Commission on White House Fellowships
2. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
3. Signalife Appoints Lee Ehrlichman President and Chief Operating Officer
4. MAP Pharmaceuticals Appoints Marco Rosa Vice President of Human Resources
5. Clarient Names Raymond J. Land Senior Vice President and Chief Financial Officer
6. Abt Associates Names Richard Small Vice President and Chief Financial Officer
7. Schering-Plough Appoints Janet M. Barth Vice President, Investor Relations
8. Orchid Cellmark Appoints Jeffrey S. Boschwitz as Vice President, North America Marketing & Sales
9. Takedas Antibody Therapeutics Research Company, Takeda San Francisco, Inc. Appoints Mary Haak-Frendscho, Ph.D. as President and CSO
10. Board Certified Dermatologist and President-Elect of the Dermatologic Society of Greater New York, Dr. Lance H. Brown Takes His Comprehensive Practice to East Hampton, NY
11. Michael V. Novinski, Emisphere President/CEO Featured in the Wall Street Transcript
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... BIRMINGHAM, AL (PRWEB) , ... June 28, 2017 ... ... of new spinal technologies, is pleased to announce the 500th case using the ... fusion system with uniquely designed titanium screws. SiCure can be implanted in ...
(Date:6/28/2017)... ... 2017 , ... Supplies of the critical medical isotope molybdenum-99 (Mo-99) are secure ... Nuclear Medicine and Molecular Imaging (SNMMI) 2017 annual meeting in Denver, Colorado in June. ... to 40 million nuclear medicine procedures worldwide every year. (1) , Sally Schwarz, ...
(Date:6/27/2017)... Shirley, NY (PRWEB) , ... June 27, 2017 , ... ... lift assist and ambulation aid in one device. This assistive aid lifts patients safely ... a safety harness and motorized lift mechanics. The Mobility Assist is the latest in ...
(Date:6/26/2017)... , ... June 26, 2017 , ... ... Melissa Kirkegaard, the former Associate Director of Product Development R&D at Allergan and ... pharmaceutical products at both start-up and established biopharma companies, has joined the firm ...
Breaking Biology Technology:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):